Skip to main content
Caplight Logo









NoorDx

NoorDx

Private
ThuwalHealthcare & Life Scienceshttps://www.noordx.sa/

Last Round

Series A

Mar 1, 2022

Total Funding Raised

$2.48M

Company Overview

NoorDx is a biotechnology company that provides clinical genomics, precision medicine, and genetic testing services to support healthcare and research in Saudi Arabia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

genetic testinggenomic diagnosticsprecision medicinemolecular diagnosticsbioinformaticsclinical laboratoryreverse transcription polymerase chain reactionRT-PCRgenomic researchpreventative screeningbiotechclinical genomicsvariant callinggenomic data analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NoorDx Comparables

Compare NoorDx with similar companies based on industry and business-model similarity.

NoorDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anwa BioSciences
86%
Novo Genomics
86%
Enigma Genomics
83%

NoorDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 1, 2022
AcceleratorSep 17, 2018

NoorDx Investors

Notable investors and investment history

NoorDx investors
InvestorRounds
King Abdullah University of Science and Technology (KAUST)Accelerator
KAUST Innovation VenturesSeries A
TAQADAMAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Monthly visitors grew 114% MoM, reaching 5.8K.

  • Nov 7, 2025

    Monthly visitors grew 156% MoM, reaching 2.7K.

NoorDx Filings

Explore SEC and related filing metadata, where available.

NoorDx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NoorDx's valuation, stock price, and market status.

Is NoorDx a public or private company?

NoorDx is a private company.

What is the current stock price of NoorDx?

NoorDx is a private company, so its shares have no public market price. Caplight tracks NoorDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is NoorDx worth (valuation)?

Valuation information for NoorDx is not publicly available.

Can I buy NoorDx stock?

NoorDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was NoorDx's last funding round?

NoorDx's most recent funding round was Series A on March 1, 2022.

Who are the main investors in NoorDx?

Key investors in NoorDx include King Abdullah University of Science and Technology (KAUST), KAUST Innovation Ventures, TAQADAM.

Will NoorDx IPO soon?

No public IPO plans have been announced for NoorDx.

How can I track NoorDx secondary market activity?

Caplight tracks bids, offers, and trades in NoorDx's shares on secondary markets.

Firmographic Details

HeadquartersThuwal
Employee Range8
Year Founded2017
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?